Drug details

Elucirem (gadopiclenol injection)

type of Gadolinium-Containing Contrast Agents

Elucirem (gadopiclenol) is a gadolinium-based contrast agent indicated in adult and pediatric patients aged 2 years and older for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal vascularity in the central nervous system (brain, spine, and associated tissues) and the body (head and neck, thorax, abdomen, pelvis, and musculoskeletal system).

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat, and
• dizziness

The following drugs are related to Elucirem, either as a replacement or used together:

• Clariscan (gadoterate meglumine injection)
• Dotarem (gadoterate meglumine for use with magnetic resonance imaging)
• Eovist (gadoxetate disodium injection)
• Gadavist (gadobutrol)
• MultiHance (gadobenate dimeglumine injection)
• Omniscan (gadodiamide)
• Magnevist (gadopentetate dimeglumine)
• Vueway (gadopiclenol injection)
• ProHance Multipack (gadoteridol injection)
• ProHance (gadoteridol injection solution)
• OptiMARK (gadoversetamide injection)